RxDoctor Payments Data

Chantelle Niles, PA

Medical · Minneapolis, KSNPI 1033668967

Payments from drug & device makers

$1,132in general payments, 2019–2025

Across 69 payments — averaging $16.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$245
  • AbbVie$243
  • Amgen$159
  • Lilly USA, LLC$155
  • Pfizer$103
  • AstraZeneca$68
  • plus $159 from 6 others

What the payments were for

  • Food & beverage$1,132100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,132 in reported general payments places this provider in the 55th percentile of 205 medical providers in Kansas.

See all medical providers in Kansas

Medicare billing

Part B allowed, 2024
$9,332
Medicare patients
41
Services billed
143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide26$24,478
EliquisApixaban28$15,622
MounjaroTirzepatide13$14,153
JanumetSitagliptin Phos/Metformin Hcl15$12,102
Modafinil14$8,777
Budesonide24$6,002
LinzessLinaclotide11$5,611
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen109$3,153
Gabapentin151$3,090
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,439
Levalbuterol Hcl19$2,260
PremarinEstrogens, Conjugated11$2,152
Atorvastatin Calcium236$1,999
Fentanyl11$1,782
Desvenlafaxine Succinate ErDesvenlafaxine Succinate19$1,751

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$245$24,47826 claims
PfizerEliquis, Premarin$103$17,77339 claims
Lilly USA, LLCMounjaro$155$14,15313 claims
AbbVieLinzess$243$5,61111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 205 medical providers in Kansas.

Other medical in Minneapolis

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →